Published in Cancer Weekly, April 14th, 1997
The sponsored project combines the complementary technical and commercial expertise of the two companies in the development of in vitro immunoassays that can monitor the treatment progress of cancer patients from a doctor's office.
The collaborative project entails the development and commercialization of immunodiagnostic kits that can monitor the progress of the disease during the treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.